{"podcast":{"title":"Stocks To Watch","slug":"stocks-to-watch-5696376","podcast_index_feed_id":5696376,"rss_url":"https://stockstowatch.podomatic.com/rss2.xml","website_url":"https://www.podomatic.com/podcasts/stockstowatch","image_url":"https://assets.podomatic.net/ts/7a/39/41/ziga10954/1400x1400_16741795.png","author":"Global One Media Pte. Ltd.","episode_count":826,"summary":"Enjoy exclusive interviews with industry leaders from a wide range of listed small—and mid-cap companies and stay updated with the latest market and industry trends.Hosted by Ashleigh Barry, Jon Franklin, Kyle Livingston and Moneer Barazi, along with contributors, Don Durrett and John Feneck, Global One Media invites top leaders and influencers from the crypto, small, and mid-cap space to join them for informative and in-depth discussions. With each episode, investors are provided with quality insights that are easy to digest and understand. Get the inside scoop on the latest global trends and insights from leaders in various industries. Enjoying our episodes? Follow our podcast and hit the notification bell so that you don’t miss any new episodes.Watch our Stock To Watch interviews on YouTube: https://www.youtube.com/@GlobalOneMedia?sub_confirmation=1","last_synced_at":"2026-07-01T06:18:32.689786+00:00","page_url":"https://stenobird.com/podcast/stocks-to-watch-5696376"},"episode":{"title":"Episode 819: Cardiol Therapeutics ($CRDL): A New Approach to Treating Inflammation in Heart Disease","slug":"episode-819-cardiol-therapeutics-crdl-a-new-approach-to-treating-inflammation-in-heart-disease","published_at":"2026-05-19T21:12:34+00:00","page_url":"https://stenobird.com/podcast/stocks-to-watch-5696376/episode-819-cardiol-therapeutics-crdl-a-new-approach-to-treating-inflammation-in-heart-disease","show_page_url":"https://stenobird.com/podcast/stocks-to-watch-5696376","url":"https://www.podomatic.com/podcasts/stockstowatch/episodes/2026-05-19T14_12_34-07_00","audio_url":"https://pdcn.co/e/stockstowatch.podomatic.com/enclosure/2026-05-19T14_12_34-07_00.mp3?_=1779225154.17776903","summary":"This interview is disseminated on behalf of Cardiol Therapeutics Inc. In this episode of Stocks to Watch, we sit down with David Elsley, President and CEO of Cardiol Therapeutics (NASDAQ: CRDL | TSX: CRDL), to discuss the company's late-stage clinical development program targeting inflammation-driven heart conditions, including recurrent pericarditis and acute myocarditis. Learn more: https://www.cardiolrx.com Watch the full YouTube interview here: https://youtu.be/NXkzgfWHQnA And follow us to stay updated: https://www.youtube.com/GlobalOneMedia","meta_description":"This interview is disseminated on behalf of Cardiol Therapeutics Inc. In this episode of Stocks to Watch, we sit down with David Elsley, President and CEO…","key_points":[],"chapters":[],"topics":[],"duration_seconds":854,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/stocks-to-watch-5696376/episodes/episode-819-cardiol-therapeutics-crdl-a-new-approach-to-treating-inflammation-in-heart-disease/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/stocks-to-watch-5696376/episode-819-cardiol-therapeutics-crdl-a-new-approach-to-treating-inflammation-in-heart-disease.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}